ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 1541.HK
1541.HK
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 6660.HK
AIM Vaccine Co., Ltd. 6996.HK
Antengene Corporation Limited 3880.HK
Medtide Inc. 2561.HK
VISEN Pharmaceuticals 2197.HK
Clover Biopharmaceuticals, Ltd. 1873.HK
Viva Biotech Holdings 2509.HK
Qyuns Therapeutics Co., Ltd. 1477.HK
Ocumension Therapeutics 1167.HK
Jacobio Pharmaceuticals Group Co., Ltd.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 6660.HK
AIM Vaccine Co., Ltd. 6996.HK
Antengene Corporation Limited 3880.HK
Medtide Inc. 2561.HK
VISEN Pharmaceuticals 2197.HK
Clover Biopharmaceuticals, Ltd. 1873.HK
Viva Biotech Holdings 2509.HK
Qyuns Therapeutics Co., Ltd. 1477.HK
Ocumension Therapeutics 1167.HK
Jacobio Pharmaceuticals Group Co., Ltd.
Performance
| Periode | 1541.HK | 6660.HK | 6996.HK | 3880.HK | 2561.HK | 2197.HK | 1873.HK | 2509.HK | 1477.HK | 1167.HK |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 106.93 % | 19.51 % | 82.40 % | -2.60 % | -7.09 % | 1 042.86 % | 78.52 % | 217.56 % | 60.80 % | 134.08 % |
| YTD | 122.34 % | -34.67 % | 616.18 % | -2.60 % | -40.17 % | 869.70 % | 183.53 % | 308.87 % | 68.20 % | 478.74 % |
| 1Y | 93.52 % | -41.84 % | 479.76 % | -2.60 % | -40.17 % | 578.79 % | 161.96 % | 91.30 % | 25.12 % | 286.84 % |
| 3Y | -46.47 % | -79.79 % | 40.75 % | -2.60 % | -40.17 % | 25.14 % | 73.38 % | 16.65 % | -23.07 % | 67.43 % |
| 5Y | -46.47 % | -76.47 % | -73.36 % | -2.60 % | -40.17 % | -82.74 % | -69.65 % | 16.65 % | -66.36 % | -49.03 % |
| 10Y | -46.47 % | -76.47 % | -73.36 % | -2.60 % | -40.17 % | -82.74 % | -45.48 % | 16.65 % | -79.27 % | -49.03 % |
| Depuis le début | -46.47 % | -76.47 % | -73.36 % | -2.60 % | -40.17 % | -82.74 % | -45.48 % | 16.65 % | -79.27 % | -49.03 % |